KLS Keeping Law Simple Legislation in plain English

Straight-ahead summaries built from the official bill text. We keep the source links front and center and leave the decision up to you.

Back to Indiana

SB157 • 2026

A BILL FOR AN ACT to amend the Indiana Code concerning insurance.

A BILL FOR AN ACT to amend the Indiana Code concerning insurance.

Passed Legislature

This bill passed both chambers and reached final enrollment, even if later executive action is not shown here.

Sponsor
Senator Mike Bohacek
Last action
2026-01-28
Official status
Engrossed Senate Bill (H)
Effective date
Not listed

Plain English Breakdown

The official source material does not provide details on enforcement or calculation methods, leaving these aspects unclear.

Law About Drug Costs

This law requires pharmacists or pharmacies to provide information about the national average drug acquisition cost when selling a generic drug.

What This Bill Does

  • Requires certain pharmacists or pharmacies to include the amount of the national average drug acquisition cost for a generic drug on written materials given to customers at the point of sale.

Who It Names or Affects

  • Pharmacists and pharmacies that sell generic drugs
  • People who buy generic drugs from these places

Terms To Know

Generic drug
A less expensive version of a brand-name drug, which has the same active ingredients.
National average drug acquisition cost
The typical price that pharmacies pay to get generic drugs from suppliers.

Limits and Unknowns

  • Does not specify what happens if a pharmacist or pharmacy does not follow this rule.
  • It is unclear how the national average drug acquisition cost will be calculated and provided to pharmacists.
  • The law has passed both chambers of the Indiana legislature but its final approval and implementation details are still pending.

Amendments

These notes stay tied to the official amendment files and metadata from the legislature.

SB0157.01.INTR.AMS01

Committee Introduced Senate Bill (S) • Senator Mike Bohacek

Filed

Plain English: The amendment adds new requirements for insurance companies to provide information about prescription drug costs and alternatives.

  • Insurance companies must disclose the cost of a prescribed drug and any lower-cost alternatives when requested by a patient or their representative.
  • The exact details on how insurance companies will implement these disclosures are not specified in the amendment text.
SB0157.02.COMS.AMS001

Filed Senate Bill (S) • Senator Mike Bohacek

Passed

Plain English: This amendment changes the Indiana Code to include new requirements for insurance policies.

  • Adds new rules about what information must be included in insurance policies.
  • The official text does not provide specific details on what new information is required, making it hard to explain exactly which parts of insurance policies will change.

Bill History

  1. 2026-01-28 House

    First reading: referred to Committee on Public Health

  2. 2026-01-27 Senate

    Referred to the House

  3. 2026-01-26 Senate

    Third reading: passed; Roll Call 72: yeas 44, nays 0

  4. 2026-01-26 Senate

    House sponsor: Representative Goss-Reaves

  5. 2026-01-26 Senate

    Cosponsor: Representative Barrett

  6. 2026-01-26 Senate

    Senator Crider added as second author

  7. 2026-01-22 Senate

    Second reading: amended, ordered engrossed

  8. 2026-01-22 Senate

    Amendment #1 (Bohacek) prevailed; voice vote

  9. 2026-01-15 Senate

    Committee report: amend do pass, adopted

  10. 2026-01-15 Senate

    Senator Randolph added as coauthor

  11. 2026-01-06 Senate

    Senator Jackson L added as coauthor

  12. 2026-01-05 Senate

    Authored by Senator Bohacek

  13. 2026-01-05 Senate

    First reading: referred to Committee on Insurance and Financial Institutions

Official Summary Text

A BILL FOR AN ACT to amend the Indiana Code concerning insurance.
Disclosures related to prescription drugs.

Current Bill Text

Read the full stored bill text 
A BILL FOR AN ACT to amend the Indiana Code concerning insurance.

Disclosures related to prescription drugs.

Requires certain pharmacists or pharmacies to provide the amount of the national average drug acquisition cost for a generic drug on the written materials provided to an individual at the point of sale of the generic drug.